Cargando…

Correction: Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593719/ https://www.ncbi.nlm.nih.gov/pubmed/34782434 http://dx.doi.org/10.1136/jitc-2021-002968corr1

Ejemplares similares

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML
por: Herbrich, Shelley, et al.
Publicado: (2021)

Correction: Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling
Publicado: (2015)

Correction: Population Genomics of the Immune Evasion (var) Genes of Plasmodium falciparum
por: Barry, Alyssa E, et al.
Publicado: (2007)

Correction: Japanese Encephalitis Virus Activates Autophagy as a Viral Immune Evasion Strategy
por: Jin, Rui, et al.
Publicado: (2013)

Correction: Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Publicado: (2022)

Use of an anti‐CD200‐blocking antibody improves immune responses to AML in vitro and in vivo
por: Rastogi, Namrata, et al.
Publicado: (2020)

Expression of CD200 on AML blasts directly suppresses memory T-cell function
por: Coles, S J, et al.
Publicado: (2012)

Interaction of CD200 Overexpression on Tumor Cells with CD200R1 Overexpression on Stromal Cells: An Escape from the Host Immune Response in Rectal Cancer Patients
por: Bisgin, Atil, et al.
Publicado: (2019)

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021)

Correction to: CD33 BiTE(®) molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
por: Marcinek, Anetta, et al.
Publicado: (2023)

Correction: SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough Infection
por: Sahni, Chetan, et al.
Publicado: (2023)

Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
por: Huang, Xiaoyuan, et al.
Publicado: (2021)

Correction: On the mechanism of anti-CD39 immune checkpoint therapy
Publicado: (2020)

Mechanisms of immune evasion by head and neck cancer stem cells
por: Xavier, Flávia Caló Aquino, et al.
Publicado: (2022)

Correction: Evasion of Immunity to Plasmodium falciparum: Rosettes of Blood Group A Impair Recognition of PfEMP1
por: Moll, Kirsten, et al.
Publicado: (2016)

Correction: Phosphorylation of Mouse Immunity-Related GTPase (IRG) Resistance Proteins Is an Evasion Strategy for Virulent Toxoplasma gondii
por: Steinfeldt, Tobias, et al.
Publicado: (2015)

Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2022)

Immune evasion by cancer stem cells
por: Tsuchiya, Hiroyuki, et al.
Publicado: (2021)

CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human
por: Varin, Audrey, et al.
Publicado: (2013)

Author Correction: CD200R/Foxp3-mediated signalling regulates microglial activation
por: Yi, Min-Hee, et al.
Publicado: (2020)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML
por: Yilmaz, Musa, et al.
Publicado: (2021)

Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
Publicado: (2023)

Immune Evasion Mechanism and AXL
por: Son, Hye-Youn, et al.
Publicado: (2021)

Filoviral Immune Evasion Mechanisms
por: Ramanan, Parameshwaran, et al.
Publicado: (2011)

Immune evasion mechanisms of arenaviruses
por: Ly, Hinh, et al.
Publicado: (2015)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Viral mechanisms of immune evasion
por: Alcami, Antonio, et al.
Publicado: (2000)

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018)

Correction to Lancet Child Adolesc Health 2021; 5: 190–200
Publicado: (2021)

Correction to Lancet Child Adolesc Health 2020; 4: 185–200
Publicado: (2020)

Correction: Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+ and CD4+ T Cell Functionality
Publicado: (2015)

Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
por: Bi, Yazhen, et al.
Publicado: (2022)

Correction to: c-MYC overexpression induces choroid plexus papillomas through a T-cell mediated inflammatory mechanism
por: Merve, Ashirwad, et al.
Publicado: (2019)

Correction: Correction: Engineered Promoters for Potent Transient Overexpression
Publicado: (2016)

Correction: Depletion of CD4(+) CD25(+) Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Publicado: (2014)

Correction: Detection and Characterization of CD133(+) Cancer Stem Cells in Human Solid Tumours
por: Tirino, Virginia, et al.
Publicado: (2008)

Specificity of CD200/CD200R pathway in LPS-induced lung inflammation
por: Patoine, Dany, et al.
Publicado: (2022)

Mechanisms of immune evasion in breast cancer
por: Bates, Joshua P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ogklet37k3rmvnrjnob9ttavk7